Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival

Background: In Asia, large-scale studies on anti-HER2 treatment in HER2-positive breast cancer patients with brain metastases are limited. We studied the treatment patterns of these patients in Asia to evaluate the impact of anti-HER2 treatment on the time to occurrence of brain metastases (TTBM) an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2012-09, Vol.107 (7), p.1075-1082
Hauptverfasser:	Yap, Y S, Cornelio, G H, Devi, B C R, Khorprasert, C, Kim, S B, Kim, T Y, Lee, S C, Park, Y H, Sohn, J H, Sutandyo, N, Wong, D W Y, Kobayashi, M, Landis, S H, Yeoh, E M, Moon, H, Ro, J
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1059 692/699/67/1347 692/699/67/322 Adult Aged Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - therapeutic use Biological and medical sciences Biomedical and Life Sciences Biomedicine Brain Neoplasms - drug therapy Brain Neoplasms - enzymology Brain Neoplasms - pathology Brain Neoplasms - secondary Brain research Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - enzymology Breast Neoplasms - pathology Cancer Research Cancer therapies Chemotherapy Clinical Study Drug Resistance Epidemiology Female Hospitals Humans Medical records Medical research Medical sciences Metastasis Middle Aged Molecular Medicine Neurology Observational studies Oncology Protein Kinase Inhibitors - therapeutic use Quinazolines - therapeutic use R&D Radiation therapy Receptor, ErbB-2 - antagonists & inhibitors Receptor, ErbB-2 - biosynthesis Research & development Retrospective Studies Trastuzumab Tumors Tumors of the nervous system. Phacomatoses Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!